Core IM | Internal Medicine Podcast cover image

#189 Bisphosphonates and Fracture Prevention Trial: Beyond Journal Club with NEJM Group

Core IM | Internal Medicine Podcast

00:00

What was the design of the zoledronate primary prevention trial?

Hosts introduce Boland et al.'s trial enrolling women 50–60 without osteoporosis randomized to single, two, or no zoledronate doses with 10-year follow-up.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app